🏀 March Madness Special 🏀 20% Off Every Order in March 🏀 No code needed — applied at checkout! 🏀
Cognitive & Nootropic Research Hub
Selank, Semax, Dihexa & Neuroprotective Peptides
A focused research collection on cognitive-enhancing and neuroprotective peptides — covering Selank, Semax, Dihexa, Cerebrolysin, NAP peptide, and BDNF/NGF signaling pathways. Designed for researchers studying neurotrophin modulation, anxiolytic mechanisms, and cognitive function.
Lead Compounds
Selank, Semax, Dihexa
Primary Research Area
Cognitive & Neuroprotection
Key Mechanism
BDNF/NGF upregulation
Research Articles
11+ peer-reviewed overviews
All Cognitive & Nootropic Articles
9 articlesSelank: A Synthetic Heptapeptide Under Investigation for Anxiolytic and Nootropic Properties in Research Models
Selank is a synthetic heptapeptide analogue of tuftsin studied in experimental models for its anxiolytic and nootropic properties, with research focusing on its modulation of GABA, serotonin, and BDNF signaling pathways.
Semax: An ACTH(4-7) Analogue in Neuroprotection and Cognitive Research
Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment, developed in Russia and studied for neuroprotective, nootropic, and anxiolytic properties. Research has demonstrated effects on BDNF expression, dopaminergic and serotonergic systems, and cognitive function in animal models and clinical studies.
Selank: Anxiolytic Peptide Research and GABAergic Modulation
A review of Selank's documented anxiolytic properties, GABA-A receptor modulation, and neurotrophic effects in published preclinical and clinical research.
Semax: BDNF Upregulation and Neuroprotection Research
A review of Semax's documented effects on BDNF expression, neuroprotection, and cognitive function in published preclinical and clinical research.
Cognitive Research: Semax + Selank + NAD+ Combination Study
A mechanistic review of the Semax, Selank, and NAD+ combination for cognitive research, examining how the three compounds target complementary aspects of neurological function.
Selank: Anxiolytic Peptide Research and GABAergic Modulation
A review of Selank's pharmacology, including its proposed GABAergic mechanism, BDNF upregulation effects, and the published evidence from Russian clinical trials.
Semax: BDNF Upregulation and Neuroprotection Research
A review of Semax's pharmacology, including its ACTH-derived structure, BDNF upregulation mechanism, and the published evidence for neuroprotective effects in animal models and clinical studies.
Neurotrophin Signaling: How Peptides May Support BDNF and NGF
A review of neurotrophin biology (BDNF, NGF, NT-3) and how research peptides including Semax, Selank, and BPC-157 interact with neurotrophin signaling pathways.
Dihexa: Cognitive Enhancement Research and the HGF/c-Met Pathway
An overview of Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide), a potent hepatocyte growth factor (HGF) modulator studied in experimental models for its effects on synaptic connectivity, memory, and neurological repair.
FOR RESEARCH PURPOSES ONLY — All content in this hub is intended strictly for scientific and educational reference. These compounds are not approved for human or animal consumption. Pure Pharm Peptides sells exclusively to qualified researchers.